Alkermes Q4 2021 Earnings Report
Key Takeaways
Alkermes reported Q4 2021 revenues of $324.5 million and GAAP net income of $0.9 million, or $0.01 per share. Non-GAAP net income was $38.5 million, or $0.23 per share. The company provided financial expectations for 2022, reflecting a focus on proprietary products and continued operating efficiency.
Total revenues for the quarter were $324.5 million.
GAAP net income was $0.9 million for the quarter, or a basic and diluted GAAP earnings per share of $0.01.
Non-GAAP net income was $38.5 million for the quarter, or a non-GAAP basic earnings per share of $0.24 and diluted earnings per share of $0.23.
Alkermes recorded cash, cash equivalents and total investments of $765.7 million at Dec. 31, 2021.
Alkermes
Alkermes
Alkermes Revenue by Segment
Forward Guidance
Alkermes provided financial expectations for 2022, assuming improvement in COVID-19 pandemic-related disruptions beginning in the second quarter and reflecting the removal of all royalties from worldwide sales of the long-acting INVEGA products beginning in 2022.
Revenue & Expenses
Visualization of income flow from segment revenue to net income